Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Compass Therapeutics
Biotech
Roche, Vir, Neurocrine & more—Chutes & Ladders
Roche bids adieu to pharma vet Sabry. Vir fills vacant CMO spot. Neurocrine maps out CEO succession plan.
Gabrielle Masson
,
Fraiser Kansteiner
,
Andrea Park
May 31, 2024 8:30am
Compass inks Trigr takeover to land clinical-phase bispecific
May 14, 2021 8:35am
Compass aims at $50M IPO to push lead antibody through clinic
Oct 20, 2020 9:50am
Compass' immuno-oncology prospect clears solid tumors in mice
Apr 3, 2020 8:50am
Biomatics raises $300M fund, recruits biopharma vets
Nov 8, 2018 10:10am
2018’s Fierce 15 on biotech investment and the next decade
Oct 3, 2018 11:06am